SCN Signs Strategic, Regional Agreement for Coldizin and Immulina in South Eastern Europe
Scandinavian Clinical Nutrition AB (SCN) has entered into an exclusive, strategic distribution and supply agreement for the patented products Coldizin and Immulina in South Eastern Europe with a leading company in the Greek health market, Alapis S.A.Under the agreement, Alapis S.A. will exclusively market and distribute Coldizin and Immulina each in eight countries: Greece, Serbia, Bulgaria, Romania, Croatia, Slovenia, Montenegro, Bosnia-Herzegovina, FYRM and Albania. The initial focus will be the launch of both SCN products in Greece and Serbia during Q3 2009, with the other markets to